Ujvin Nevatia
17 Apr • 4:30 PM · SEBI-Registered Analyst
Windlas Biotech Announces ₹47 Crore Buyback at ₹1,000, Record Date Set
Windlas Biotech Ltd. Share Price
Overview
Windlas Biotech Ltd. share price is currently ₹929.05, down by - ₹10.35 (1.1%) from its previous closing price of ₹939.40. The share price has declined -17.94% over the past month and gained 0.73% over the past year. The stock's 52-week low and high are ₹691.90 and ₹1,164.83, respectively. Windlas Biotech Ltd. has a market capitalisation of ₹ 1,959.00 Cr. The share price was last updated on 12 Oct 2026, 03:29 PM IST.
Updated: 12 Oct 2026, 03:29:50 pm IST
Market Data
Open Price
₹937.56Prev. Close
₹939.40Day Low
Day High
52 Week Low
52 Week High
Fundamentals
Quick Bite
Price To Earnings Ratio
29.33Sector PE
42.62PB Ratio
3.49Sector PB
5.63EPS
31.68Dividend Yield
0.85Today's Volume
43.849 K5 Day Avg. Volume
89.109 KPEG Ratio
3.58Market Cap.
₹ 1,959.00 Cr.StockGro Trade views
Technical Analysis
Forecasts 🧭
Financials
Corporate Actions
Mutual Fund Ownership
Mutual Fund Holder | Aug 26 Shares held | Sep 26 Shares held |
|---|---|---|
| ICICI Prudential Healthcare Fund - Growth | 4.04 Lac | 3.56 Lac (11.89%) |
| UTI Healthcare Fund - Regular Plan - IDCW | 1.86 Lac | 1.86 Lac (0.25%) |
| Bandhan Small Cap Fund - Regular Plan - Growth | 2.69 Lac | 96.82 k (64.02%) |
| Motilal Oswal BSE Healthcare ETF | 215 | 212 (1.4%) |
| Bandhan BSE Healthcare Index Fund - Regular Plan - Growth | 101 | 100 (0.99%) |
About Windlas Biotech Ltd. 👋
Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables.
Expert Opinions
Insights from SEBI-registered analysts · updated live
Power Of Finance (SEBI RA)
20 Mar • 12:52 PM · SEBI-Registered Analyst
Windlas Biotech Shareholders Approve Re-appointment of Three Directors Through Postal Ballot
Nikita (SEBI RA)
3 Mar • 2:14 PM · SEBI-Registered Analyst
“Why Weak Trends Show Deep Pullbacks”
In weak trends, corrections are aggressive and deep.
This signals lack of strong participation.
Warning signs:
Large counter-trend candles
Break of minor structure
Slow recovery after dips
Learning:
Deep pullbacks often indicate fragile momentum.
Jeet B Bhayani (SEBI RA)
20 Dec • 11:20 PM · SEBI-Registered Analyst
In the past decade, India has installed a total of 2,361 MW of biomass power projects and 228 MWe of waste-to-energy projects within the bioenergy sector. Furthermore, a total of 2.88 lakh biogas plants have been set up across the nation to promote the use of sustainable energy alternatives. The advancements in this field have been aided by the ongoing support for the National Bioenergy Programme (NBP), Phase I, which was announced with a budget of Rs. 998 Crore (approximately US$120 million) for the duration from 2022-2023 to 2025-2026. The Ministry of New and Renewable Energy has aided the expansion of the bioenergy sector by providing Central Financial Assistance to projects through various schemes aimed at developing biomass power, bio-CNG, biogas, and waste-to-energy initiatives.
The strategic actions taken by the government involve offering financial aid incentives for generating energy from biogas and agro-industrial waste, advocating the development of bio-CNG facilities, and providing subsidies for setting up biomass cogeneration plants. These efforts have led to a rapid increase in renewable energy installations in states such as Maharashtra, Karnataka, and Punjab, which have emerged as leaders in the sector's growth.
Sohrab Shaikh (SEBI RA)
20 Jul • 1:15 PM · SEBI-Registered Analyst
Companies having ex dividend date on 21.7.25
1. Accelertebs India final dividend Rs. 0.2 per share
2. Anupam Rasayan India Interim dividend Rs. 0.75 per share
3. OCCL final dividend Rs. 1.5 per share
4. Orient Bell final dividend Rs. 0.5 per share
5. Shree Cement final dividend Rs. 60 per share
6. Windlas Biotech final dividend Rs. 5.8 per share
Shaly Gupta
18 Nov • 3:44 PM · SEBI-Registered Analyst
Very Good quarter for many Pharma companies High Double digit growth (17-22%)💹 Lot of Interesting names⏬ ~ Windlas ~ Supriya ~ Marksans Pharma ~ SMS ~ Caplin Point ~ Innova Cap
See MoreFrequently Asked Questions
What is the share price of Windlas Biotech Ltd.?
What is the market cap of Windlas Biotech Ltd.?
Should I buy Windlas Biotech Ltd. stock now?
What is the 52 week high and low of Windlas Biotech Ltd.?
Is the Windlas Biotech Ltd. stock good to buy?
Is Windlas Biotech Ltd. a good buy for the long term?
Is Windlas Biotech Ltd. overvalued or undervalued?
What is the PE and PB ratio of Windlas Biotech Ltd.?
Today's market leaders and laggards
CP Capital Ltd.
CPCAP
₹174.61
+31.19 (21.75%)
West Coast Paper Mills Ltd.
WSTCSTPAPR
₹868.54
+149.86 (20.85%)
Gallantt Ispat Ltd.
GALLANTT
₹592.62
+98.25 (19.87%)
The New India Assurance Company Ltd.
NIACL
₹186.32
+26.82 (16.82%)
Mawana Sugars Ltd.
MAWANASUG
₹166.61
+21.42 (14.75%)